Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Race against time: does getting ERCP within 24 hours save lives?

NCT ID NCT05920954

Disease control Sponsor: Asian Institute of Gastroenterology, India Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 304 patients with mild to moderate acute cholangitis, a serious bile duct infection. Researchers compared performing ERCP (a drainage procedure) within 24 hours versus waiting 24 to 48 hours. The goal was to see if faster treatment reduces deaths within 30 days and other complications.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ERCP (a procedure to drain the bile duct)
What this could lead to
If urgent ERCP proves better, it could set a new standard for how quickly patients with this serious bile duct infection need treatment.
What could go wrong
This is a single-center study with 304 patients, so results may not apply everywhere. The difference between 24 and 48 hours may be small, and the study is already completed without a clear breakthrough.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

304 people

The number who actually took part.

Started

Jun 2023

Finished

Jul 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients who met criteria for a definite diagnosis acute cholangitis. Exclusion Criteria: * Patients with severe acute cholangitis at admission. * Age \< 18 years. * Pregnancy. * Associated Acute Severe Pancreatitis. * Patients with suspected high grade (Bismuth III/IV) biliary stricture in whom PTBD is considered as primary method of biliary drainage. * Not giving consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute cholangitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute cholangitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute cholangitis

Contacts and locations

Locations

  • AIG Hospitals

    Hyderabad, Telangana, 500032, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.